hip replacement implants - global pipeline analysis

1. Hip Replacement Implants - Global Pipeline Analysis,Competitive Landscape and Market Forecasts to 2017

2. The Global Hip Replacement Implants Market is forecast to reach $8.6 billion in 2017, After Growing at a CAGR of 5% during 2010–2017 The global hip replacement implants market is expected to grow at a CAGR of 5% from 2010, to reach $8.6 billion in 2017. The market is expected to grow due to rising incidence of osteoarthritis in the aging population and increase in obesity. Osteoarthritis is the most common type of arthritis. Studies by the Center for Disease Control (CDC) have indicated that arthritis affects nearly 43 million Americans, and it is estimated that this will increase to 67 million or 25% of the adult population by 2030. Of this, workingage adults (45–64 years) will account for almost one-third of cases. Direct to consumer (DTC) marketing in the US, the fact that hip replacement surgeries can reduce the burden of healthcare expenditure on government and other payers, and the lack of alternative medical treatment options, are other contributing factors for market growth. Primary Hip Replacement Implants is the Major Segment within the Hip Replacement Implants Market Primary hip replacement implants is the major segment within the hip replacement implants market, and was valued at $4.7 billion in 2010. This market is expected to grow at a CAGR of 6% over the period 2010–2017, to reach revenues of $6.8 billion in 2017. The launch of new products with personalized fit, multiple design options and advanced bearing technologies has positively impacted the growth of the primary hip replacement implants market.

3. The increase in surgeries in younger patients due to the need to remain active will further stimulate the growth of this market. Increasing Number of Patients Suffering from Osteoarthritis to Drive Hip Replacement Implants Procedures Osteoarthritis is the most common form of arthritis in the US and other Western countries. It is increasing in incidence as the population ages, and it is likely to rise further with the obesity epidemic. Although the degenerative process may accelerate in persons with a previous hip injury, many cases of osteoarthritis occur when the hip simply wears out. Osteoarthritis is the highest-ranking disease among the musculoskeletal diseases, and contributes to approximately 50% of the disease burden in this group. According to the WHO (World Health Organization), osteoarthritis is expected to be the fourth leading cause of non-fatal burden of disease by 2020. Hence, there is a continuous increase in the incidence rate of osteoarthritis, supplemented by aging and obesity, which would propel the number of hip replacement surgeries. For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Hip-Replacement-Implants-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report

4. Rheumatoid arthritis and traumatic arthritis are other factors that lead to loss of hip function and immobility. The US is the Key Market for Hip Replacement Implants The US hip replacement implants market was valued at $2.8 billion in 2010. The market has grown at a CAGR of 6% over the period 2003–2010. The US hip replacement implants market is expected to grow at a CAGR of 6% over the period 2010–2017, to reach $4 billion by 2017. The US was the biggest market for hip replacement implants in the period 2003-2010, and held 47% of the global market share in 2010. The US market grew due to higher awareness among patients from direct to consumer marketing and the launch of new products. The future growth in the hip replacement implants market will be due to an increase in the elderly population in the US, in whom there is greater likelihood of osteoarthritis and hip fracture. The primary hip replacement implants market was valued at $2.1 billion in 2010, and is expected to grow at a CAGR of 6% in the period 2010-2017 to reach $3.2 billion. The partial hip replacement implants market was valued at $348.7m in 2010, and is expected to grow at a CAGR of 5% to reach $499.1m in 2017. The revision hip replacement implants market was valued at $290.9m in 2010, and is expected to grow at a CAGR of 5% to reach $416.5m in 2017.

5. DePuy Inc is the global leader in the hip replacement implants market, with revenues of $1.3 billion, and 22% of the market share in 2010. Other companies with significant presence in the hip replacements market include Zimmer, Stryker, Smith & Nephew and Biomet. The hip replacement implants market is dominated by established market players. The presence of new, small companies is not pronounced in the market. GlobalData’s new report, “Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global hip replacement implants market. The report provides market landscape, competitive landscape and market trends information on the hip replacement implants market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Hip-Replacement-Implants-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report

6. visit our report store: http://www.globaldata.com For more details contact: pressreleases@globaldata.com North America: +1 646 395 5477 Europe: +44 207 753 4299 +44 1204 543 533 Asia Pacific: +91 40 6616 6782